 PRESS RELEASE: REGULATED INFORMATION17 January 2023, 17:40 CET BIOCARTIS MEETS 2022 KEY OBJECTIVES Mechelen, Belgium, 17 January 2023 Biocartis Group NV the Company or Biocartis, an innovative molecular diagnostics company Euronext Brussels: BCART, announces that the Company has achieved its 2022 key business objectives focused on three performance indicators: IdyllaTM product revenues, gross margins on... The post Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES app... 